Increased serum or urinary concentrations of neopterin have been described in patients with tumors of different primary locations, including colorectal cancer. Neopterin concentrations were reported to increase during the administration of cytotoxic agents, including taxane-based chemotherapy.
We have studied serum neopterin in patients with colorectal cancer before and during the therapy with patupilone.